HOME >> MEDICINE >> NEWS
Long-term use of oral contraceptives could increase risk of cervical cancer for women with HPV

Women who are positive for the sexually transmitted human papillomavirus (HPV) could be at a three times greater risk of cervical cancer if they have used oral contraceptives for five years or longer, suggest authors of a study in this weeks issue of THE LANCET. However, there is no evidence that long-term oral-contraceptive use increases the risk of cervical cancer in the absence of HPV.

The absolute risk of cervical cancer ranges from around 1% in developed countries to 5% in less-developed settings. The effect of HPV-the main cause of cervical cancer-has not usually been taken into account in previous studies investigating a possible link between oral-contraceptive use and cervical cancer. Victor Moreno and colleagues from the International Agency for Research on Cancer (IARC) aimed to assess how use of oral contraceptives affected risk of cervical cancer in women who tested positive for HPV DNA.

The investigators pooled data from eight case-control studies of patients with histologically confirmed invasive cervical carcinoma (ICC) and from two studies of patients with carcinoma in situ (ISC [a precursor of ICC]). Information about use of oral contraceptives was obtained from personal interviews. Data were available for around 1900 women from Thailand, the Philippines, Morocco, Brazil, Peru, Paraguay, Colombia, and Spain.

94% of women with ICC, 72% with ISC, and 13% of women without cervical cancer were positive for HPV DNA. Compared with women who had never used oral contraceptives, those who had used oral contraceptives for fewer than 5 years did not have an increased risk of cervical cancer. Women who used oral contraceptives for between five and nine years were around three times more likely to have cervical cancer; there was a four-fold increased risk for oral contraceptive use of 10 years or more.

Silvia Franceschi comments: "We think that our results lend support to the existence of an association between oral contracept
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
27-Mar-2002


Page: 1 2

Related medicine news :

1. Long-term high consumption of red and processed meat linked with increased risk for colon cancer
2. Long-term data show benefit of DETROL LA as first-line therapy for overactive bladder
3. Long-term benefits for newly diagnosed patients with CML receiving first-line therapy with imatinib
4. Long-term obesity linked to loss of brain tissue in women
5. Long-term study demonstrated ADDERALL XR is an effective option to treat adolescents with ADHA
6. Long-term study proves ADDERALL XR is a safe and effective option to treat adults with ADHD
7. Long-term use of antibiotics possibly linked with increased risk of breast cancer
8. Long-term follow-up of mortality in patients with community-acquired pneumonia
9. Long-term outcome of epilepsy surgery is favorable for many
10. Long-term ERT in postmenopausal women with Alzheimers may worsen memory
11. Long-term avoidance of milk in children results in poor bone health

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... Reflections Recovery ... now accredited by The Joint Commission for chemical dependency and behavioral health services. ... U.S. health care organizations that meet the commission’s rigorous standards. Accreditation by The ...
(Date:9/20/2017)... ... September 20, 2017 , ... FirstAlign ... (CoE) with the latest Artificial Intelligence (AI) thinking, announced today the launch of ... easy access to essential information that offers a more comprehensive understanding of the ...
(Date:9/20/2017)... Ashburn, Virginia (PRWEB) , ... September 20, 2017 ... ... Spartacote Flex Pure Clinical Plus Coating System for clients that rely on safety ... inhibit the growth of microorganisms. , Silver has been used for centuries for ...
(Date:9/20/2017)... ... September 20, 2017 , ... On ... Best Places to Work in the Research Triangle for 2017. , Winners were ... company had to meet a threshold in employee participation--a percentage that varies based ...
(Date:9/20/2017)... ... September 20, 2017 , ... Renal Support Network’s annual essay ... kidney disease. The theme “Describe a positive decision that you have made about ... meet only one qualification— to have been diagnosed with chronic kidney disease. This ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , ... Allentown, Penn. , and OptiMed Specialty Pharmacy of ... business partnership to offer a strategic hub service that ... Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, and ... A spirometer is a medical device used to ...
Breaking Medicine Technology:
Cached News: